Literature DB >> 22514456

Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario.

S Wasfy1, J Nishikawa, M Petric.   

Abstract

The prevalence of antibody to parvovirus B19 was assessed in two populations. In a group of 494 residents from Ontario and the Maritimes, virus-specific immunoglobulin (Ig) M antibody, a marker of acute infection, was found throughout the year but was most prevalent during the late winter and early spring months. The overall prevalence of IgG antibody in this group was 30.3%. In an effort to examine age-specific prevalence in this population, a second group of sera from 210 pediatric patients at The Hospital for Sick Children, Toronto, Ontario and from Red Cross blood donors was tested for the presence of B19-specific IgG, and of these, 31.4% of the samples were positive. This prevalence varied from 3.3% in the under five-year-old age group to 66.7% in the 35- to 45-year-old age group. Eighty per cent of sera from females of this group were seropositive. This study provides insight into the prevalence of parvovirus B19 IgG antibody in the population.

Entities:  

Keywords:  Human parvovirus B19; Seroprevalence

Year:  1996        PMID: 22514456      PMCID: PMC3327426          DOI: 10.1155/1996/941356

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  20 in total

1.  Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Authors:  G J Kurtzman; B Cohen; P Meyers; A Amunullah; N S Young
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

Review 2.  Role of parvovirus B19 in human disease.

Authors:  L J Anderson
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

3.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

4.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

5.  Human parvovirus B19 infections in women of childbearing age and within families.

Authors:  W C Koch; S P Adler
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

6.  Risk of human parvovirus B19 infections among school and hospital employees during endemic periods.

Authors:  S P Adler; A M Manganello; W C Koch; S H Hempfling; A M Best
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

7.  Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum.

Authors:  D D Erdman; M J Usher; C Tsou; E O Caul; G W Gary; S Kajigaya; N S Young; L J Anderson
Journal:  J Med Virol       Date:  1991-10       Impact factor: 2.327

8.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

9.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

10.  Human parvovirus arthropathy.

Authors:  D G White; A D Woolf; P P Mortimer; B J Cohen; D R Blake; P A Bacon
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

View more
  4 in total

Review 1.  Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Gabriele Calizzani; Fabio Candura; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

2.  Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India.

Authors:  Rajlakshmi Viswanathan; Babasaheb V Tandale; Manisha S Tamayachekar; Santoshkumar M Jadhav; Kirtee A Khutwad; Kiran R Munne
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

3.  Pediatric anti-NMDA receptor encephalitis is seasonal.

Authors:  Laura A Adang; David R Lynch; Jessica A Panzer
Journal:  Ann Clin Transl Neurol       Date:  2014-10-30       Impact factor: 4.511

4.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.